|
Name |
Diportharine A
|
Molecular Formula | C15H18O4 | |
IUPAC Name* |
4,5,7-trihydroxy-3-pent-1-enyl-3,4-dihydro-2H-naphthalen-1-one
|
|
SMILES |
CCCC=CC1CC(=O)c2cc(O)cc(O)c2C1O
|
|
InChI |
InChI=1S/C15H18O4/c1-2-3-4-5-9-6-12(17)11-7-10(16)8-13(18)14(11)15(9)19/h4-5,7-9,15-16,18-19H,2-3,6H2,1H3/b5-4+
|
|
InChIKey |
JOBBZKBAFUCADB-SNAWJCMRSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 262.3 | ALogp: | 2.7 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 77.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 19 | QED Weighted: | 0.729 |
Caco-2 Permeability: | -4.587 | MDCK Permeability: | 0.00001290 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.012 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.059 |
30% Bioavailability (F30%): | 0.539 |
Blood-Brain-Barrier Penetration (BBB): | 0.149 | Plasma Protein Binding (PPB): | 78.25% |
Volume Distribution (VD): | 1.013 | Fu: | 18.08% |
CYP1A2-inhibitor: | 0.396 | CYP1A2-substrate: | 0.864 |
CYP2C19-inhibitor: | 0.185 | CYP2C19-substrate: | 0.246 |
CYP2C9-inhibitor: | 0.376 | CYP2C9-substrate: | 0.942 |
CYP2D6-inhibitor: | 0.553 | CYP2D6-substrate: | 0.495 |
CYP3A4-inhibitor: | 0.175 | CYP3A4-substrate: | 0.145 |
Clearance (CL): | 9.843 | Half-life (T1/2): | 0.829 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.021 |
Drug-inuced Liver Injury (DILI): | 0.253 | AMES Toxicity: | 0.404 |
Rat Oral Acute Toxicity: | 0.251 | Maximum Recommended Daily Dose: | 0.065 |
Skin Sensitization: | 0.533 | Carcinogencity: | 0.157 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.807 |
Respiratory Toxicity: | 0.08 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005853 | 0.415 | D07MGA | 0.284 | ||||
ENC003216 | 0.415 | D0O1UZ | 0.264 | ||||
ENC002936 | 0.415 | D0L7AS | 0.248 | ||||
ENC006107 | 0.415 | D0P1FO | 0.234 | ||||
ENC004535 | 0.410 | D0YF3X | 0.231 | ||||
ENC006044 | 0.408 | D07EXH | 0.226 | ||||
ENC001509 | 0.385 | D04AIT | 0.222 | ||||
ENC005292 | 0.377 | D0K8KX | 0.217 | ||||
ENC003550 | 0.368 | D02UFG | 0.211 | ||||
ENC003360 | 0.364 | D06FEA | 0.210 |